Introduction: Little is known about the requests for and recommendations from inpatient pediatric palliative care (PPC) consults and whether they differ by patient location (ward vs. intensive care unit) or patient type (new vs. established with PPC).
Methods: Single-center, retrospective cohort study comparing PPC consult requests and recommendations for children who received a PPC consult between January 1, 2018 and June 30, 2019. Comparisons were made by patient location and patient type using bivariate statistics.
Results: Three hundred twenty-seven PPC encounters were evaluated. Symptoms were more likely to be addressed in consults for ward patients than for intensive care unit patients. Compared with established patients, consults for new patients occurred significantly later in the hospital course and were more likely to be for psychosocial support or goals of care.
Discussion: We found variability in PPC consult requests and recommendations that may inform future work and targeted education for primary providers.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9038641 | PMC |
| http://dx.doi.org/10.1016/j.pedhc.2021.10.004 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Do Land Use Plans Affirmatively Further Fair Housing?: Measuring Progress.
J Am Plann Assoc
July 2023
Berkeley, California.
Problem Research Strategy And Findings: The 1968 Fair Housing Act required local government recipients of federal money to take meaningful actions to affirmatively further fair housing (AFFH). Current fair housing analysis requirements are copious but do not request an assessment of how land use policies affect the potential for neighborhood integration. A recent California law requires local governments to include AFFH analysis in existing planning processes, and state guidelines encourage the measurement of the spatial distribution of planned sites for low-income housing with respect to opportunity.
View Article and Find Full Text PDFExplainable machine learning models for identifying mild cognitive impairment in older patients with chronic pain.
BMC Nurs
January 2025
Department of Pain Medicine, the 1st affiliated hospital, Jiangxi Medical College, Nanchang University, 17 Yongwai Street, Nanchang, China.
Background: Mild cognitive impairment (MCI) is prevalent in older adults with chronic pain, making early detection crucial for dementia prevention and healthy aging. This study aimed to determine MCI risk factors in older patients with chronic pain and to develop 9 machine learning models to identify MCI risk.
Methods: A total of 612 older patients with chronic pain were recruited between October 2023 and July 2024.
The qualified presumption of safety (QPS) process was developed to provide a safety assessment approach for microorganisms intended for use in food or feed chains. In the period covered by this Statement, no new information was found that would change the status of previously recommended QPS taxonomic units (TUs). The TUs in the QPS list were updated based on a verification, against their respective authoritative databases, of the correctness of the names and completeness of synonyms.
View Article and Find Full Text PDFTowards personalized immersive virtual reality neurorehabilitation: a human-centered design.
J Neuroeng Rehabil
January 2025
Dept. of Cognitive Robotics, TU Delft, Delft, Netherlands.
Background: Head-mounted displays can be used to offer personalized immersive virtual reality (IVR) training for patients who have suffered an Acquired Brain Injury (ABI) by tailoring the complexity of visual and auditory stimuli to the patient's cognitive capabilities. However, it is still an open question how these virtual environments should be designed.
Methods: We used a human-centered design approach to help define the characteristics of suitable virtual training environments for ABI patients.
Safety, Tolerability, and Pharmacokinetics of a Novel Anti-obesity Agent, S-309309, in Healthy Adults with or Without Obesity.
Clin Drug Investig
January 2025
Medical Science Department, Shionogi & Co., Ltd., Osaka, Japan.
Background: Anti-obesity medications are recommended for patients who do not achieve and maintain weight loss despite lifestyle interventions. S-309309 is a novel oral inhibitor of monoacylglycerol O-acyltransferase 2 being developed as a treatment for obesity.
Objective: The objective of the study was to investigate the safety, clinical pharmacology, pharmacokinetics and pharmacodynamic biomarker of S-309309.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!